308 related articles for article (PubMed ID: 36597150)
21. A brief review on long noncoding RNAs: a new paradigm in breast cancer pathogenesis, diagnosis and therapy.
Malih S; Saidijam M; Malih N
Tumour Biol; 2016 Feb; 37(2):1479-85. PubMed ID: 26662315
[TBL] [Abstract][Full Text] [Related]
22. Downregulation of the long non-coding RNA ZFAS1 is associated with cell proliferation, migration and invasion in breast cancer.
Fan S; Fan C; Liu N; Huang K; Fang X; Wang K
Mol Med Rep; 2018 May; 17(5):6405-6412. PubMed ID: 29532866
[TBL] [Abstract][Full Text] [Related]
23. The novel long non‑coding RNA PRNCR1‑2 is involved in breast cancer cell proliferation, migration, invasion and cell cycle progression.
Pang D; Hu Q; Lan X; Lin Y; Duan H; Cao S; Lin Y; Li L; Peng F; Pan F
Mol Med Rep; 2019 Mar; 19(3):1824-1832. PubMed ID: 30592261
[TBL] [Abstract][Full Text] [Related]
24. Long non-coding RNA LINC00665 promotes metastasis of breast cancer cells by triggering EMT.
Zhou JL; Zou L; Zhu T
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):3097-3104. PubMed ID: 32271427
[TBL] [Abstract][Full Text] [Related]
25. Long non-coding RNAs (LncRNA) regulated by transforming growth factor (TGF) β: LncRNA-hit-mediated TGFβ-induced epithelial to mesenchymal transition in mammary epithelia.
Richards EJ; Zhang G; Li ZP; Permuth-Wey J; Challa S; Li Y; Kong W; Dan S; Bui MM; Coppola D; Mao WM; Sellers TA; Cheng JQ
J Biol Chem; 2015 Mar; 290(11):6857-67. PubMed ID: 25605728
[TBL] [Abstract][Full Text] [Related]
26. Long non-coding RNAs as monitoring tools and therapeutic targets in breast cancer.
Pecero ML; Salvador-Bofill J; Molina-Pinelo S
Cell Oncol (Dordr); 2019 Feb; 42(1):1-12. PubMed ID: 30361825
[TBL] [Abstract][Full Text] [Related]
27. Circulating non-coding RNAs as a diagnostic and management biomarker for breast cancer: current insights.
Hosseinalizadeh H; Mahmoodpour M; Ebrahimi A
Mol Biol Rep; 2022 Jan; 49(1):705-715. PubMed ID: 34677714
[TBL] [Abstract][Full Text] [Related]
28. Long non-coding RNA mediated drug resistance in breast cancer.
Singh D; Assaraf YG; Gacche RN
Drug Resist Updat; 2022 Jul; 63():100851. PubMed ID: 35810716
[TBL] [Abstract][Full Text] [Related]
29. Long non-coding RNA GHET1 promotes human breast cancer cell proliferation, invasion and migration via affecting epithelial mesenchymal transition.
Song R; Zhang J; Huang J; Hai T
Cancer Biomark; 2018; 22(3):565-573. PubMed ID: 29843220
[TBL] [Abstract][Full Text] [Related]
30. Concise approach for screening long non-coding RNAs functionally linked to human breast cancer associated genes.
Shin TJ; Lee KH; Cho HM; Cho JY
Exp Mol Pathol; 2019 Jun; 108():89-96. PubMed ID: 30953646
[TBL] [Abstract][Full Text] [Related]
31. Long non-coding RNAs and exosomal lncRNAs: Potential functions in lung cancer progression, drug resistance and tumor microenvironment remodeling.
Entezari M; Ghanbarirad M; Taheriazam A; Sadrkhanloo M; Zabolian A; Goharrizi MASB; Hushmandi K; Aref AR; Ashrafizadeh M; Zarrabi A; Nabavi N; Rabiee N; Hashemi M; Samarghandian S
Biomed Pharmacother; 2022 Jun; 150():112963. PubMed ID: 35468579
[TBL] [Abstract][Full Text] [Related]
32. Spotlight on Exosomal Non-Coding RNAs in Breast Cancer: An In Silico Analysis to Identify Potential lncRNA/circRNA-miRNA-Target Axis.
Ashekyan O; Abdallah S; Shoukari AA; Chamandi G; Choubassy H; Itani ARS; Alwan N; Nasr R
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955480
[TBL] [Abstract][Full Text] [Related]
33. LncRNA-CDC6 promotes breast cancer progression and function as ceRNA to target CDC6 by sponging microRNA-215.
Kong X; Duan Y; Sang Y; Li Y; Zhang H; Liang Y; Liu Y; Zhang N; Yang Q
J Cell Physiol; 2019 Jun; 234(6):9105-9117. PubMed ID: 30362551
[TBL] [Abstract][Full Text] [Related]
34. Long non-coding NR2F1-AS1 is associated with tumor recurrence in estrogen receptor-positive breast cancers.
Sanchez Calle A; Yamamoto T; Kawamura Y; Hironaka-Mitsuhashi A; Ono M; Tsuda H; Shimomura A; Tamura K; Takeshita F; Ochiya T; Yamamoto Y
Mol Oncol; 2020 Sep; 14(9):2271-2287. PubMed ID: 32392629
[TBL] [Abstract][Full Text] [Related]
35. Molecular and Cellular Changes in Breast Cancer and New Roles of lncRNAs in Breast Cancer Initiation and Progression.
Kumar M; DeVaux RS; Herschkowitz JI
Prog Mol Biol Transl Sci; 2016; 144():563-586. PubMed ID: 27865468
[TBL] [Abstract][Full Text] [Related]
36. Research Progress on Long Non-coding RNAs and Drug Resistance of Breast Cancer.
Zhang X; Yang H
Clin Breast Cancer; 2020 Aug; 20(4):275-282. PubMed ID: 32414649
[TBL] [Abstract][Full Text] [Related]
37. Long non coding RNA OIP5‑AS1 promotes metastasis of breast cancer via miR‑340‑5p/ZEB2 axis.
Meng L; Yue X; Zhou D; Li H
Oncol Rep; 2020 Oct; 44(4):1662-1670. PubMed ID: 32945479
[TBL] [Abstract][Full Text] [Related]
38. m
Bian Y; Wang Y; Xu S; Gao Z; Li C; Fan Z; Ding J; Wang K
Cells; 2022 Sep; 11(19):. PubMed ID: 36230970
[TBL] [Abstract][Full Text] [Related]
39. Comprehensive analysis of the aberrantly expressed lncRNA‑associated ceRNA network in breast cancer.
Tuersong T; Li L; Abulaiti Z; Feng S
Mol Med Rep; 2019 Jun; 19(6):4697-4710. PubMed ID: 31059025
[TBL] [Abstract][Full Text] [Related]
40. Microarray expression profile analysis of long non-coding RNAs in human breast cancer: a study of Chinese women.
Xu N; Wang F; Lv M; Cheng L
Biomed Pharmacother; 2015 Feb; 69():221-7. PubMed ID: 25661361
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
